Skip to main content
. 2020 Jul 20;117(31):18771–18779. doi: 10.1073/pnas.2001887117

Fig. 1.

Fig. 1.

The necroptosis pathway and mechanism of action of small molecule necroptosis inhibitors. Two inhibitors of the necroptotic pathway were utilized in this study: GSK′872, which inhibits RIP3 kinase activity (21, 22), and necrosulfonamide (NSA), which inhibits downstream effector functions of MLKL via covalent reaction with human MLKL residue Cys86 (19, 23).